Routine genetic analysis in patients suspected of POMC deficiency is recommended not only to guide lonγ-term prognosis and tailor the personalized management of these patients per se, but also to enable discovery of breakthrough treatments for important public health problems such as obesity. This evidence concerns the gene POMC and obesity due to melanocortin 4 receptor deficiency.